Biomerica (BMRA) Capital Expenditures Growth (3y) (2013 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 10.17% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 1.81% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.84% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.35% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.08% |
| 10 | Biomerica | 7.12 Mn | 5.78 Mn | -44,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2024 | -6.22% |
| Nov 30, 2023 | -35.13% |
| Aug 31, 2023 | -19.05% |
| Feb 28, 2023 | -34.55% |
| Nov 30, 2022 | 79.47% |
| Aug 31, 2022 | 150.19% |
| May 31, 2022 | -4.63% |
| Feb 28, 2022 | -10.31% |
| Nov 30, 2021 | -4.48% |
| Aug 31, 2021 | -48.70% |
| May 31, 2021 | -19.63% |
| Feb 28, 2021 | 28.34% |
| Nov 30, 2020 | -12.63% |
| Aug 31, 2020 | 25.61% |
| May 31, 2020 | 185.82% |
| Feb 29, 2020 | -32.68% |
| May 31, 2019 | 9.35% |
| Feb 28, 2019 | -21.90% |
| Nov 30, 2018 | -12.79% |
| Aug 31, 2018 | 88.56% |
| May 31, 2018 | 211.90% |
| Feb 28, 2018 | 2,102.89% |
| Nov 30, 2017 | 87.74% |
| Aug 31, 2017 | 75.82% |
| May 31, 2017 | -76.68% |
| Feb 28, 2017 | 27.92% |
| May 31, 2016 | 40.87% |
| Feb 29, 2016 | 81.34% |
| Nov 30, 2015 | -49.66% |
| Aug 31, 2015 | -55.67% |
| May 31, 2015 | -60.19% |
| Feb 28, 2015 | -97.15% |
| Nov 30, 2014 | -20.34% |
| Aug 31, 2014 | -54.68% |
| May 31, 2014 | -29.78% |
| Feb 28, 2014 | 19.52% |
| Nov 30, 2013 | 9.33% |
| Aug 31, 2013 | 9.90% |